[1] Chamoli A, Gosavi AS, Shirwadkar UP, et al.Overview of oral cavity squamous cell carcinoma. Risk factors, mechanisms, and diagnostics[J]. Oral Oncology, 2021, 12(1): 405-410. [2] 朱慧,祖木热提古丽·阿不来提,孙二灿,等. ACLY和LPCAT1在口腔鳞状细胞癌中的表达及临床意义[J]. 农垦医学,2023,45(4):294-298. [3] 张梦,汤隽,张树玲,等. 靶向表皮生长因子受体的泛素化修饰[J]. 中国医科大学学报,2023,52(6):549-552. [4] Alexander PB, Yuan L, Yang P, et al.EGF promotes mammalian cell growth by suppressing cellular senescence[J], Cell Res, 2015, 25(1): 135-138. [5] 曾洁,祖木热提古丽·阿不来提,马琰迪,等. 口腔鳞状细胞癌中IGF1的表达及其临床意义[J]. 安徽医科大学学报,2023,58(8):1418-1423. [6] 姚文若,宫焱熹,徐琪鸿,等. 石河子地区非小细胞肺癌PDL–1表达水平与EGFR及临床相关参数的关系[J]. 农垦医学,2021,43(4):317-320. [7] Gharat SA, Momin M, Bhavsar C.Oral Squamous Cell Carcinoma. Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy[J]. Crit Rev Ther Drug, 2016, 33(4): 363-400. [8] 刘艳春,贾儒渊,樊志慧,等. 表皮生长因子受体在食管鳞状细胞癌组织中的表达及其临床意义[J]. 临床误诊误治,2024,37(10):35-38. [9] Chakravarthy K, Pavithra V, Joseph LD, et al.Overexpression of EGFR in esophageal squamous cell carcinomas-A new biological target in cancer therapy[J]. J Cancer Res Ther, 2023, 19(2): 461-465. [10] 熊丙万,柯文飞,江文洋. 分子靶向治疗在EGFR突变肺鳞癌中的研究进展[J]. 中国肺癌杂志,2024,27(4):283-290. [11] Zubair T, Bandyopadhyay D.Small Molecule EGFR Inhibitors as Anti-Cancer Agents. Discovery, Mechanisms of Action, and Opportunities[J]. Int J Mol Sci, 2023, 24(3): 26-31. [12] 曲伟伟,崔艳红,许学宗,等. NSCLC患者外周血AEC水平与肿瘤组织中相关指标表达的相关性及联合检测对预后的预测价值[J]. 现代肿瘤医学,2026,34(2):227-233. [13] Rasheed Abubakir S, Hidayat HJ.Molecular study of colorectal carcinoma and EGFR gene mutations[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(9): 177-182. [14] Guo G, Gong K, Beckley N, et al.EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation[J]. Nature Cell Biology, 2022, 24(8): 1291-1305. [15] 高鹏,苏博,罗冲. SOX2、EGFR在胃癌组织中的表达及与其临床病理特征的关系研究[J]. 实用癌症杂志,2025,40(1):79-82. |